E-Bike Commuting and Health in Overweight College Students (NCT07114991) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
E-Bike Commuting and Health in Overweight College Students
United States60 participantsStarted 2025-05-01
Plain-language summary
This study will evaluate the effects of using a pedal-assist electric bicycle (e-bike) for commuting on physical activity, fitness, and health in overweight or obese college students. Participants will be randomly assigned to either a 12-week e-bike commuting intervention or a control group. The study will measure changes in cardiorespiratory fitness, body composition, blood biomarkers, physical activity, and psychological well-being over a 24-week period.
Who can participate
Age range
18 Years – 30 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 18-29 years
* Currently enrolled undergraduate or graduate student
* Body mass index (BMI) ≥25.0 kg/m² (classified as overweight or obese)
* Self-report of engaging in \<150 minutes per week of moderate-to-vigorous physical activity
* Able and willing to safely ride a bicycle for commuting or transportation purposes
* Willing to be randomized and complete all study procedures across 24 weeks Able to provide informed consent
Exclusion Criteria:
* Current use of a bicycle or e-bike for commuting ≥2 times per week
* Known cardiovascular, metabolic, or orthopedic conditions that limit physical activity or make exercise testing unsafe
* Currently pregnant, planning pregnancy during the study period, or less than 6 months postpartum
* Use of medications known to affect glucose metabolism, heart rate, or physical activity (e.g., beta-blockers, insulin)
* Diagnosed severe mental health disorders that would impair study participation
* Participation in another clinical trial or lifestyle intervention within the past 3 months
* Inability or unwillingness to attend lab visits or comply with the intervention protocol
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in daily moderate-to-vigorous physical activity (minutes/day)
Timeframe: From enrollment to end of study at 24 weeks.
2
Change in cardiorespiratory fitness (VO₂peak, mL/kg/min)
Timeframe: From enrollment to end of study at 24 weeks.